Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands (Q43574355)

24 November 2017

Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands (English)

1 reference

24 November 2017

10

1 reference

24 November 2017

Ferry G

1

1 reference

24 November 2017

Bruneau V

2

1 reference

24 November 2017

Beauverger P

3

1 reference

24 November 2017

Goussard M

4

1 reference

24 November 2017

Rodriguez M

5

1 reference

24 November 2017

Lamamy V

6

1 reference

24 November 2017

Dromaint S

7

1 reference

24 November 2017

Canet E

8

1 reference

24 November 2017

Galizzi JP

9

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Journal of Pharmacology

24 November 2017

1 reference

24 November 2017

417

1 reference

24 November 2017

1-2

1 reference

24 November 2017

77-89

1 reference

PPAR gamma is required for placental, cardiac, and adipose tissue development

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptors: nuclear control of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Ligand-induced peroxisome proliferator-activated receptor alpha conformational change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Biological activities and mechanisms of action of PGJ2 and related compounds: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Orphan nuclear receptors: from gene to function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Induction of apoptosis, p53 and heme oxygenase-1 by cytotoxic prostaglandin delta12-PGJ2 in transformed endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Biological activities of prostaglandin H1 analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliterator-activated receptors, orphans with ligands and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Medical significance of peroxisome proliferator-activated receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

The PPARs: from orphan receptors to drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900907-4

10.1016/S0014-2999(01)00907-4

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference